The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Pim kinase-dependent inhibition of c-Myc degradation
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Delineation of prognostic biomarkers in prostate cancer
Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., & Chinnaiyan, A. M. (2001) · Nature · doi:10.1038/35090585 · Cited by 1,673
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,393
c-MYC: more than just a matter of life and death
Pelengaris, S., Khan, M., & Evan, G. (2002) · Nature Reviews Cancer · doi:10.1038/nrc904 · Cited by 1,178
Myc-driven murine prostate cancer shares molecular features with human prostate tumors
Ellwood-Yen, K., Graeber, T. G., Wongvipat, J., Iruela-Arispe, M. L., Zhang, J., Matusik, R., Thomas, G. V., & Sawyers, C. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00197-1 · Cited by 816
Yeh, E., Cunningham, M., Arnold, H., Chasse, D., Monteith, T., Ivaldi, G., Hahn, W. C., Stukenberg, P. T., Shenolikar, S., Uchida, T., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1110 · Cited by 791
Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging
van Lohuizen, M., Verbeek, S., Scheljen, B., Wientjens, E., van der Guidon, H., & Berns, A. (1991) · Cell · doi:10.1016/0092-8674(91)90382-9 · Cited by 762
Theo Cuypers, H., Selten, G., Quint, W., Zijlstra, M., Maandag, E. R., Boelens, W., van Wezenbeek, P., Melief, C., & Berns, A. (1984) · Cell · doi:10.1016/0092-8674(84)90309-x · Cited by 639
The Myc oncoprotein as a therapeutic target for human cancer
Vita, M., & Henriksson, M. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.015 · Cited by 552
van Lohuizen, M., Verbeek, S., Krimpenfort, P., Domen, J., Saris, C., Radaszkiewicz, T., & Berns, A. (1989) · Cell · doi:10.1016/0092-8674(89)90589-8 · Cited by 496
Amati, B. (1998) · Frontiers in Bioscience · doi:10.2741/a239 · Cited by 367
Cited by
For better or for worse: the role of Pim oncogenes in tumorigenesis
Nawijn, M. C., Alendar, A., & Berns, A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2986 · Cited by 481
Therapeutic targeting of “undruggable” MYC
Llombart, V., & Mansour, M. R. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2021.103756 · Cited by 472
Brault, L., Gasser, C., Bracher, F., Huber, K., Knapp, S., & Schwaller, J. (2010) · Haematologica · doi:10.3324/haematol.2009.017079 · Cited by 368
Keeton, E. K., McEachern, K., Dillman, K. S., Palakurthi, S., Cao, Y., Grondine, M. R., Kaur, S., Wang, S., Chen, Y., Wu, A., et al. (2014) · Blood · doi:10.1182/blood-2013-04-495366 · Cited by 254
PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer
Luszczak, S., Kumar, C., Sathyadevan, V. K., Simpson, B. S., Gately, K. A., Whitaker, H. C., & Heavey, S. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0109-y · Cited by 102
Metadata
- Authors
- Zhang, Y., Wang, Z., Li, X., & Magnuson, N. S.
- Venue
- Oncogene
- Published
- 2008-04-28
- Volume
- 27
- Issue
- 35
- Pages
- 4809-4819
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2048135242
- Cited by
- 265
- References
- 32
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pim kinase-dependent inhibition of c-Myc degradation. https://app.cochat.ai/papers/10.1038/onc.2008.123
- The paper
- Zhang, Y., Wang, Z., Li, X., & Magnuson, N. S. (2008). Pim kinase-dependent inhibition of c-Myc degradation. Oncogene. https://doi.org/10.1038/onc.2008.123
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.